Sign inJoin waitlistJoin the waitlist

SH

Sarah Huepenbecker

Director of Gyn Onc Research · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · ·

History

Gyn Onc Research · University of Texas M D Anderson Cancer Center
Present

Gynecologic Oncology
University of Texas M D Anderson Cancer Center
2021–2024
Obstetrics and Gynecology
Washington University/B-JH/SLCH Consortium
2016–2020
Perelman School of Medicine at the University of Pennsylvania
2012–2016

Research

The effects of defoliation on carbon allocation: can carbon limitation reduce growth in favour of storage?
Tree Physiology · 2013 · 77 citations
The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer
Gynecologic Oncology · 2016 · 40 citations
Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States
Cancer · 2021 · First of 7 authors · 39 citations

Larissa Meyer
20 papers
Pedro Ramirez
7 papers
AG
Ashley Graul
6 papers
Javier Lasala
6 papers
Sharon Giordano
6 papers
Andres Zorrilla-Vaca
5 papers · 5 as a resident
Gabriel Mena
5 papers · 1 as a resident
Allison Walker
4 papers · 1 as a fellow
David Mutch
3 papers
Jolyn Taylor
3 papers
JL
Juan Garcia Lopez
3 papers · 3 as a resident
Katherine Fuh
3 papers

Clinical trials

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034